Osteoporosis

• DOI: 10.7326/aitc202401160
• Publication Date: 2024-01-08T22:00:18Z
• Authors: Kristine E. Ensrud; Carolyn J. Crandall
• Keywords: Pharmacotherapy; Fragility fracture

Osteoporosis is a common systemic skeletal disorder resulting in bone fragility and increased fracture risk. Evidence-based screening strategies improve identification of patients who are most likely to benefit from drug treatment prevent fracture. In addition, careful consideration when pharmacotherapy should be started, choice medication, duration maximizes the benefits prevention while minimizing potential harms long-term exposure.